Search
Funobactam
go.drugbank.com/drugs/DB21541InvestigationalFunobactam is a small molecule drug. The usage of the INN stem '-bactam' in the name indicates that Funobactam is a ẞ-lactamase inhibitor. Funobactam has a monoisotopic molecular weight of 399.1 Da.
Atinvicitinib
go.drugbank.com/drugs/DB21558ExperimentalAtinvicitinib is a small molecule drug. The usage of the INN stem '-citinib' in the name indicates that Atinvicitinib is a Janus kinase inhibitor.
Fulimetibant
go.drugbank.com/drugs/DB21599ExperimentalFulimetibant is a small molecule drug. The usage of the INN stem '-tibant' in the name indicates that Fulimetibant is a bradykinin receptor antagonist.
Adrixetinib
go.drugbank.com/drugs/DB21620InvestigationalAdrixetinib is a small molecule drug. The usage of the INN stem '-tinib' in the name indicates that Adrixetinib is a tyrosine kinase inhibitor.
Friluglanstat
go.drugbank.com/drugs/DB21652ExperimentalFriluglanstat is a small molecule drug. The usage of the INN stem '-glanstat' in the name indicates that Friluglanstat is a prostaglandin synthase inhibitor.
Canlitinib
go.drugbank.com/drugs/DB21656ExperimentalCanlitinib is a small molecule drug. The usage of the INN stem '-tinib' in the name indicates that Canlitinib is a tyrosine kinase inhibitor.
Labuxtinib
go.drugbank.com/drugs/DB21658ExperimentalLabuxtinib is a small molecule drug. The usage of the INN stem '-tinib' in the name indicates that Labuxtinib is a tyrosine kinase inhibitor.
Talorasib
go.drugbank.com/drugs/DB21686ExperimentalTalorasib is a small molecule drug. The usage of the INN stem '-rasib' in the name indicates that Talorasib is a Ras protein inhibitor. Talorasib has a monoisotopic molecular weight of 604.24 Da.
Rovafovir etalafenamide
go.drugbank.com/drugs/DB14903InvestigationalRovafovir etalafenamide is under investigation in clinical trial NCT03472326 (Efficacy of GS-9131 Functional Monotherapy in HIV-1-Infected Adults Failing a Nucleos(t)Ide Reverse Transcriptase Inhibitor-Containing
TERN-101
go.drugbank.com/drugs/DB16045InvestigationalTERN-101 is under investigation in clinical trial NCT04328077 (LIFT Study: A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of TERN-101 in Subjects With Non-cirrhotic Non-alcoholic Steatohepatitis